Ondansetron and VIPoma
Delahunt, J.W.; Burgess, C.; Bott, V.
New Zealand Medical Journal 106(958): 260
1993
ISSN/ISBN: 0028-8446 PMID: 8392671 Document Number: 411447
Document emailed within 1 workday
Related Documents
Chen, P.-T.; Liaw, C.-C. 2008: Intravenous ondansetron plus intravenous dexamethasone with different ondansetron dosing schedules during multiple cycles of cisplatin-based chemotherapy Chang Gung Medical Journal 31(2): 167-174Egorov, A.V.; Kuzin, N.M.; Lakreeva, M.G. 1999: Vipoma of pancreas Khirurgiia 4: 68-72
Procacciante, F.; Picozzi, P.; Fantini, A.; Pacifici, M.; Di Nardo, A.; Ribotta, G.; Delle Fave, G.; Catani, M.; Ruggeri, S.; Romeo, F. 1992: VIPoma: surgical treatment Minerva Chirurgica 47(3-4): 135-142
Drouet, A.; Ferrer, X.; Julien, J.; Lagueny, A. 1991: Hypokalemic paralysis disclosing vipoma Annales de Medecine Interne 142(2): 146-147
Dobrzańska, A.; Rowecka-Trzebicka, R.; Socha, J.; Stodulski, J.; Woźniewicz, B. 1983: VIPoma as a cause of chronic diarrhea in a 3-year-old boy Pediatria Polska 58(1): 103-107
Yanagi, H.; Kusunoki, M.; Sakanoue, Y.; Shoji, Y.; Yamamura, T.; Murai, M.; Kikkawa, N.; Utsunomiya, J. 1991: Vipoma of the pancreas complicating ulcerative colitis American Journal of Gastroenterology 86(8): 1066-1069
Meriney, D.K. 1996: Pathophysiology and management of VIPoma: a case study Oncology Nursing Forum 23(6): 941
Charleux, H. 1982: The Verner-Morrison syndrome: endocrine cholera or vipoma? La Nouvelle Presse Medicale 11(11): 859-862
Nagorney, D.M.; Bloom, S.R.; Polak, J.M.; Blumgart, L.H. 1983: Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma Surgery 93(2): 348-353
Brunt, L.M.; Mazoujian, G.; O'Dorisio, T.M.; Wells, S.A. 1994: Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome Surgery 115(3): 362-369
Castle, W.M.; Jukes, A.J.; Griffiths, C.J.; Roden, S.M.; Greenstreet, Y.L. 1992: Safety of ondansetron European Journal of Anaesthesiology. Supplement 6: 63-66
Figg, W.D.; Graham, C.L.; Hak, L.J.; Dukes, G.E. 1993: Ondansetron: a novel antiemetic agent Southern Medical Journal 86(5): 497-502
Allan, G.M.; Wilson, E.; Ivers, N. 2012: Can ondansetron help children with vomiting due to gastroenteritis? Canadian Family Physician Medecin de Famille Canadien 58(2): 167
Kamenova, E. 1993: Evaluation of ondansetron as a drug for premedication Acta Physiologica et Pharmacologica Bulgarica 19(3): 67-70
Tucker, M.L.; Jackson, M.R.; Scales, M.D.; Spurling, N.W.; Tweats, D.J.; Capel-Edwards, K. 1989: Ondansetron: pre-clinical safety evaluation European Journal of Cancer and Clinical Oncology 25(Suppl 1): S79-S93
Leak, R.E.; Woodford, J.D. 1989: Pharmaceutical development of ondansetron tablets European Journal of Cancer and Clinical Oncology 25(Suppl 1): S63-S66
Finn, A.L. 1992: Toxicity and side effects of ondansetron Seminars in Oncology 19(4 Suppl 10): 53-60
Roila, F.; Ballatori, E.; Del Favero, A. 1993: Antiemetic effects of ondansetron and metopimazine New England Journal of Medicine 329(18): 1356-1357
Mathew, S.K.; Kutty, K.K.; Ramya, I.; Padmakumar, C.; Pius, P. 2016: Ondansetron-Induced Life Threatening Hypokalemia Journal of the Association of Physicians of India 64(2): 81-82
Camp-Sorrell, D. 1995: Managing an extrapyramidal reaction caused by ondansetron Oncology Nursing Forum 22(4): 718-719